Quantcast

Latest Amgen Stories

2014-09-15 16:28:40

Romosozumab Currently in Phase 3 Clinical Development, Pivotal Data Expected in 2016 THOUSAND OAKS, Calif. and BRUSSELS, Sept.

2014-09-14 20:20:15

Analysis From SHIFT Study Shows Ivabradine Reduced Cardiovascular Death or Hospitalization for Worsening Heart Failure Independent of Baseline Blood Pressure With Similar Safety Profile Across Groups THOUSAND

2014-09-10 08:32:41

Data Include Eight Year Analyses of Bone Mineral Density Results for Prolia® (Denosumab) and Further Evidence for Significant Bone-Building With Romosozumab THOUSAND OAKS, Calif., Sept.

2014-09-05 16:23:16

THOUSAND OAKS, Calif., Sept. 5, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will participate in the Morgan Stanley Global Healthcare Conference on Wednesday, Sept.

2014-09-02 08:30:29

First Marketing Authorization Application for an Oncolytic Immunotherapy in the European Union THOUSAND OAKS, Calif., Sept.

2014-09-02 08:29:42

Represents First Marketing Authorization Application in the European Union for a PCSK9 Inhibitor THOUSAND OAKS, Calif., Sept.

2014-08-28 08:28:27

Represents First BLA Submission for a PCSK9 Inhibitor THOUSAND OAKS, Calif., Aug.

2014-08-27 23:14:02

AllMed webinar provides in-depth review of the latest standard of care for the use of ESAs in the treatment of Chronic Kidney Disease. Portland, OR (PRWEB) August

2014-08-27 08:28:22

THOUSAND OAKS, Calif., Aug. 27, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the U.S.

2014-08-25 16:29:28

IRVINE, Calif., Aug. 25, 2014 /PRNewswire/ -- Western Digital Corp.


Word of the Day
onomatope
  • An imitative word; an onomatopoetic word.
The word 'onomatope' is a back-formation from 'onomatopoeia'.
Related